Michael Kolovetsios is a principal health economics, policy, and reimbursement analyst at Medtronic, focusing on coronary and renal denervation therapies in international markets. They provide strategic and analytical support to optimize market access and reimbursement for Medtronic's products. Since 2021, Michael has served on the Medical Technologies Advisory Committee at NICE, contributing to the evaluation of the clinical and cost-effectiveness of health technologies. They hold a Master's degree in Health Policy from Imperial College London and are a GPhC-registered pharmacist and a member of the Royal Pharmaceutical Society. Michael's core competencies include pharmacy, health economics, market access, health policy, and reimbursement, driven by a passion for improving health outcomes and access to value-based healthcare.
Location
United Kingdom
This person is not in the org chart
This person is not in any offices